Viatris rises after quarterly results beat estimates

Shares of generic drugmaker Viatris VTRS.O rise 2.2% to $8.9

VTRS posts Q2 adj. profit of 62 cents per share compared with analysts' estimate of 56 cents - data compiled by LSEG

Its quarterly revenue came in at $3.58 billion vs estimates of $3.47 billion

Company reaffirms its 2025 revenue forecast to be between $13.5 billion and $14 billion

Also reaffirms its annual adj. profit per share to be between $2.16 and $2.30

*J.P.Morgan says "we see continued core portfolio execution and capital deployment as key drivers of the stock from here"

Including session moves, stock down 27.8% YTD